The Requirement of Varicella Zoster Virus Glycoprotein E (gE) for Viral Replication and Effects of Glycoprotein I on gE in Melanoma Cells  by Mo, Chengjun et al.
The Requirement of Varicella Zoster Virus Glycoprotein E (gE) for Viral Replication and
Effects of Glycoprotein I on gE in Melanoma Cells
Chengjun Mo,† Jay Lee,† Marvin Sommer,† Charles Grose,* and Ann M. Arvin†,1
†Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305; and *Department of Pediatrics and Microbiology,
University of Iowa College of Medicine, Iowa City, Iowa 52242
Received October 31, 2001; returned to author for revision January 11, 2002; accepted May 14, 2002
The glycoprotein E (gE) of varicella zoster virus (VZV), encoded by ORF68, is the most abundant viral glycoprotein. In the
current experiments, we demonstrated that ORF68 deletion was incompatible with recovery of infectious virus from VZV
cosmids. Replacing ORF68 at a nonnative AvrII site in the genome restored infectivity. Further, we found that VZV gE could
be expressed under the control of the Tet-On promoter in stably transfected melanoma cell lines (Met-gE cells) without
evidence of toxicity. In these Met-gE cells, gE colocalized with -adaptin, a trans Golgi network marker, in perinuclear sites,
but did not reach plasma membranes. In order to investigate how infection altered gE localization, we made a recombinant
virus, vOka-MSPgE, with ORF68 from the VZV MSP strain. VZV MSP encodes a mutant gE protein (D150N) that lacks the mAb
epitope, 3B3 (Santos et al., Virology 275, 306–317, 2000), whereas Met-gE protein binds mAb 3B3. Within 48 h after Met-gE
cells were infected with vOka-MSPgE, the steady-state distribution of Met-gE protein extended beyond the perinuclear areas
to other cytoplasmic sites and to plasma membranes. A second recombinant, vOka-MSPgE without gI (vOka-MSPgEgI), was
constructed to investigate Met-gE protein distribution in the absence of gI. The redistribution of Met-gE protein which was
observed by 48 h after vOka-MSPgE infection did not occur until 5 days (140 h) within vOka-MSPgEgI infected cells. After
vOka-MSPgE infection of Met-gE cells, most Met-gE protein was in the final 94K mature form by 72 h. However, progression
to predominance of mature gE was delayed in Met-gE cells infected with vOka-MSPgEgI. These observations confirm our
hypothesis that VZV gE is essential, based upon the demonstration of restored infectivity after replacing ORF68 in a nonnative
site in the genome, and provide further evidence of the role of gI in facilitating the maturation and intracellular distributionKey Words: varicella zoster virus; glycoprotein E; glycop
INTRODUCTION
Varicella zoster virus (VZV) is a human alphaherpesvi-
rus that causes two diseases, varicella (chickenpox) and
herpes zoster (shingles). Herpes zoster is due to VZV
reactivation following prolonged latency in sensory gan-
glia. The herpesviral glycoproteins function at several
points in the replication cycle, including viral attachment,
entry, envelopment, cell–cell spread, and egress. The
VZV glycoproteins, gB, gC, gE, gH, gI, gK, gL, and the
putative glycoproteins, gM and gN, have some homology
with those of herpes simplex viruses 1 and 2 (HSV-1 and
HSV-2), pseudorabies virus (PRV), and other alphaherpes
viruses (reviewed by Kinchington and Cohen, 2000). It
has been proposed that VZV envelopment is completed
in the trans Golgi network (TGN) of infected cells (Ger-
shon et al., 1994; Wang et al., 2001). The VZV tegument
proteins appear to assemble with envelope glycopro-
teins at the TGN during virion formation.
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176I; protein trafficking and maturation.
VZV gE, an integral membrane protein, is the most
abundant viral glycoprotein. It is found extensively in the
cytoplasm, where it is presumed to be present in the
membranes of intracellular vesicles or organelles, as
well as on plasma membranes during productive infec-
tion. In infected cells, the mature form of gE (94K) is an
O-linked and N-linked glycoprotein (Montalvo et al., 1985;
Santos et al., 1998). The intracellular trafficking and mat-
uration of gE are not fully understood and may differ
within different cell types. Most studies of gE transport
have been done in HeLa or Cos-7 cells (Olson and
Grose, 1997, 1998; Zhu et al., 1996; Wang et al., 1998). As
defined in transient expression assays, gE has targeting
sequences for the TGN and it is transported from the ER
to the TGN in infected and gE-transfected cells (Al-
conada et al., 1998; Gershon et al., 1994). Current evi-
dence indicates that most gE in the TGN has been
retrieved selectively from the plasma membrane and
delivered to the TGN via endosomes (Gershon et al.,
1994; Wang et al., 2000). Expression of gE using the
vaccinia virus-T7 RNA polymerase transfection system
indicates that gE undergoes endocytosis from the cellof this critical VZV glycoprotein. © 2002 Elsevier Science (USA)
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back to the cell membrane (Olson and Grose, 1997, 1998;rotein
Wang et al., 2000). VZV gI is also transported to the TGN
and to plasma membranes in VZV-infected cells and in
gI-transfected cells (Alconada et al., 1996, 1998). The
mechanisms by which gI reaches the TGN have not been
fully defined. VZV gE forms heterodimers with gI. When
gE and gI are expressed in vaccinia recombinants, gI
facilitates gE endocytosis and regulates the trafficking of
the gE/gI complex, which functions as an Fc receptor on
the cell surface (Olson and Grose, 1998). VZV gE can also
serve as a navigator glycoprotein, forming complexes
that direct signal-deficient viral glycoproteins to the TGN
(Wang et al., 1998). In some cell types, gE/gI complex
formation may be important for the intracellular localiza-
tion of gI. In other cells, a critical residue in the C-
terminus allows gI to reach the TGN when it is expressed
in the absence of gE (Wang et al., 2000).
The purpose of these experiments was to further ex-
amine the role of gE in VZV replication and the contribu-
tions of gI to gE trafficking in VZV-infected cells. In pre-
vious experiments using VZV cosmids, we suggested
that gE was probably essential because no infectious
virus could be recovered when both ORF68 (gE) and
ORF67 (gI) were deleted. Infectious virus was made if
ORF67 alone was removed (Mallory et al., 1997). We
showed that gE was detected throughout the cytoplasm
and on plasma membranes of infected cells when intact
gI was present and that gE exhibited a punctate distri-
bution in its absence (Mallory et al., 1997). To prove that
gE is required for VZV replication, we made ORF68 de-
letion mutants and recombinants with ORF68 replaced in
the nonnative AvrII site. In contrast to other alphaherpes-
viruses, gE was demonstrated to be essential. When
expressed alone, as an inducible protein (Met-gE pro-
tein) in melanoma cells (Met-gE cells), gE remained
localized at perinuclear sites where -adaptin, a TGN
protein, was also detected. Localization of Met-gE to the
TGN under conditions of steady-state expression in
Met-gE cells indicated that the usual gE cycling between
the TGN and plasma membranes requires other viral
proteins.
As a strategy to examine this question further, we
made VZV recombinants containing ORF68 from the VZV
MSP strain. VZV MSP is the first gE mutant identified as
the cause of a naturally occurring human infection (San-
tos et al., 1998). This new genotype exhibits a phenotype
of accelerated cell to cell spread in cell culture and in
SCID-hu skin implants (Santos et al., 2000). The gE en-
coded by VZV MSP does not bind the monoclonal anti-
body, 3B3 (Santos et al., 2000), whereas Met-gE protein
has the 3B3 epitope. Infection of Met-gE cells with vOka-
MSPgE was associated with extensive cytoplasmic re-
distribution of Met-gE protein and its detection on
plasma membranes. These experiments are the first
report of a gE-expressing cell line and of the capacity of
MSP gE to influence gE maturation and transport. Infec-
tion of Met-gE cells with the corresponding gI deletion
virus, vOka-MSPgEgI, showed that viral proteins other
than gI mediated the redistribution of gE to some extent.
However, gI enhanced gE expression on plasma mem-
branes. In addition, the maturation of gE to its 94K form
was delayed in Met-gE cells infected with vOka-
MSPgEgI, compared with vOka-MSPgE, indicating that
MSP gE trafficking mechanisms were facilitated by its
partner, gI. These experiments document that gE is es-
sential for VZV replication and provide further evidence
that interactions between gE and gI enhance the synthe-
sis of mature gE and produce the characteristic pattern
of gE localization within infected cells.
RESULTS
Analysis of gE expression in Met-gE cells
Stable, constitutive expression of gE in melanoma
cells was not achieved in our previous experiments (un-
published data) or by Litwin et al. (1992). In the current
experiments, melanoma cells tolerated inducible expres-
sion of gE without evidence of toxicity. Five positive
clones of Met-gE cell lines were tested for gE expression
after induction with doxycycline (Dox). Two clones, Met-
gE1 and Met-gE3, showed relatively low background
without Dox and high gE expression when Dox was
added at 1 g/ml. To establish the dose-dependent ef-
fect of Dox on gE expression, Met-gE1 cells were grown
in 6-well plates for 24 h in medium containing Dox at
concentrations of 0, 0.008, 0.04, 0.2, 1.0, and 5.0 g/ml.
Western blots done with anti-gE mAb demonstrated gE
expression when cells were induced with Dox concen-
trations as low as 0.04 g/ml (Fig. 1). The gE expression
was maximal at 1 g/ml Dox and did not increase with
5.0 g/ml (Fig. 1). Three forms of gE protein, which were
approximately 75K, 90K, and 96K MW, were detected
(Fig. 1).
FIG. 1. Dose-dependent effect of doxycycline on gE expression. Met
gE cells were grown in 6-well plates for 24 h in medium containing Dox
(concentrations from 0, 0.008, 0.04, 0.2, 1.0, and 5.0 g/ml). Cell lysates
were separated by 8.5% SDS–PAGE and transferred to a nitrocellulose
membrane. Mouse anti-gE monoclonal antibody (3B3) was used as the
probe and detected with anti-mouse antibody conjugated with HRP.
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To assess Met-gE glycosylation, Met-gE cells that had
been grown for different time periods were analyzed
after treatment with endo H or O-glycosidase (Fig. 2). Of
the three forms of VZV gE that were detected by Western
blot, the 75K protein was endo-H sensitive, showing a
decrease in size to 65K (Fig. 2). The 90K and 96K Met-gE
proteins showed no alteration with O-glycosidase diges-
tion (Fig. 2), which is in contrast to the decrease in the
size of gE recovered from infected cells under these
conditions (review: Grose, 1990). These patterns were
consistent with retention of some Met-gE in the ER and
cis Golgi.
To further examine the distribution of gE in Met-gE
cells, Dox-induced Met-gE cells were examined by con-
focal microscopy using polyclonal antibody to gE and
monoclonal antibody to -adaptin. -Adaptin is a marker
for the AP-1 complex, which is restricted to clathrin-
coated membranes of the TGN (Seaman et al., 1996;
Alconada et al., 1996). Most Met-gE protein was found in
perinuclear areas (Fig. 3, center). Colocalization with
-adaptin was observed, indicating that Met-gE reached
the TGN (Fig. 3, right).
Since VZV gE also contains a TGN-targeting motif as
well as tyrosine kinase and casein kinase II modification
sequences (Olson et al., 1997; Zhu et al., 1995), ORF68 in
the Met-gE cells was sequenced to exclude the possi-
bility that mutations in these sequences might have
caused the restricted steady-state distribution of gE in
Met-gE cells; no nucleotide changes were found. The
observations indicate that trafficking of gE expressed as
a single viral protein in melanoma cells was disrupted
and suggest that gE requires other viral protein(s) as
chaperones to achieve the cytoplasmic and plasma
membrane distribution observed during VZV infection of
melanoma cells.
Effect of gE deletion and repair on the replication of
VZV in melanoma cells and in Met-gE cells
As we reported previously, infectious VZV could not be
derived from cosmids that had a dual deletion of ORF68
(gE) and ORF67 (gI) (Mallory et al., 1997). Since gI was
dispensable, we speculated that gE was probably es-
sential for viral replication. To document the requirement
of gE for VZV growth, ORF68 was removed from vOka
cosmid DNA. Removal of VZV nucleotides 115808 to
117676 from cosmid pvSpe21 resulted in a complete
deletion of the gE coding region (Fig. 4, line 5). Cotrans-
fection of cosmid clones containing full deletions in gE
(pvSpe21gE) with pvSpe5, pvPme19, and pvFsp4
yielded no detectable viral plaques. Transfections done
with two different Spe21gE cosmids were repeated
three times with the same negative result. DNA recov-
ered from transfected cells 3 weeks after cosmid trans-
fection showed no detectable VZV DNA by PCR analysis.
As a positive control, intact cosmids pvFsp4, pvSpe5,
pvPme19, and pvSpe21 were cotransfected in parallel
experiments. The intact cosmids yielded infectious virus
consistently, with plaques visible by 6–8 days after trans-
fection.
Met-gE cells incubated in the presence of Dox were
transfected with pvSpe21gE and the three intact cos-
mids to determine whether Met-gE protein could com-
plement the deletion of the gE coding sequence, ORF68,
from the cosmid. The formation of small syncytia was
observed in Met-gE-transfected cells but no infectious
virus was recovered (data not shown). The level of ex-
pression of Met-gE may have been insufficient relative to
the usual abundant synthesis of gE in VZV-infected cells
(Fig. 6, lanes 1–3 vs lanes 7–9).
Repair of gE deletion with VZV MSP gE
The cosmid, Spe21gE-MSPgE@Avr, contains ORF68
from VZV-MSP with 0.45 kb of surrounding noncoding
sequence inserted into the AvrII site of pvSpe21gE at
VZV nt 112853 in the positive orientation (Fig. 4, line 5). In
contrast to transfection with the Spe21gE cosmid, re-
storing ORF68 to the nonnative AvrII site and cotransfec-
tion with pvFsp4, pvSpe5, pvPme19, and Spe21gE-
MSPgE@Avr yielded infectious virus, which was desig-
nated vOka-MSPgE. PCR analysis showed the expected
1.9-kb deletion at the endogenous gE site in pvSpe21
(PCR fragment size decreased from 3.2 to 1.3 kb) and the
expected 2.3-kb insertion at the AvrII site in pvSpe21gE
(PCR fragment size increased from 1.1 to 3.4 kb) (data not
shown). These experiments confirm that failure to gen-
erate infectious virus using the pvSpe21gE cosmid was
due specifically to the absence of ORF68 and not to other
undetected mutations in the cosmids.
The cosmid Spe21gE/gI-MSPgE@Avr contains
ORF68 from VZV MSP inserted into the AvrII site as
described above and also has ORF67 deleted (Fig. 4, line
FIG. 2. Enzymatic digestion analysis of gE from gE expressing
melanoma cells. Met-gE cells were grown in 6-well plates for 1, 2, and
3 days in medium with () or without () 1.0 g/ml Dox. Cells induced
with Dox were used for glycosidase digestion analysis. A portion of the
product was treated with endo H or O-glycosidase as indicated. Cell
lysates were separated by 8.5% SDS–PAGE and transferred to a nitro-
cellulose membrane. Mouse anti-gE monoclonal antibody (3B3) was
used as the probe and detected with anti-mouse antibody conjugated
with HRP.
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6). Infectious virus was recovered after cotransfection of
Spe21gE/gI-MSPgE@Avr with pvFsp4, pvSpe5, and
pvPme19. Initial plaque formation took 10 days longer
than the control transfection done with intact pvSpe21
(data not shown). The pattern of initial plaque formation
and the limited cell–cell spread of vOka-MSPgEgI was
similar to that of vOkagI in melanoma cells (Mallory et
al., 1997). PCR analysis showed the expected 2.3-kb
insertion at the AvrII site in pvSpe21gE (PCR fragment
size increased from 1.1 to 3.4 kb) (data not shown). These
results confirmed that gI was dispensable for VZV repli-
cation in melanoma cells (Mallory et al., 1997).
Effect of gI deletion on gE distribution in
superinfected Met-gE cells
To further assess the contribution of gI to the intracel-
lular distribution of gE, Met-gE cells were infected with
vOka-MSPgEgI in the presence of Dox. As in the vOka-
MSPgE superinfection experiments, Met-gE cells were
infected with vOka-MSPgEgI and stained with rabbit
anti-IE62 antibody to identify infected cells and with an-
ti-gE mAb, 3B3, in order to assess Met-gE protein local-
ization. The gE visualized in these experiments cannot
be MSP gE from the infecting virus because this gE lacks
the 3B3 epitope. Uninfected Met-gE cells within the
monolayer continued to show gE expression confined to
perinuclear regions (Fig. 5A, arrowheads). By 48 h,
Met-gE cells that were infected with vOka-MSPgE
showed gE detectable throughout the cytoplasm
whereas gE remained perinuclear at 48 h after vOka-
MSPgEgI infection (Fig. 5A, arrows). Since this differ-
ence might have been due to the longer replication cycle
that is characteristic of gI deletion mutants in melanoma
cells, Met-gE cells were examined for 6 days following
infection with vOka-MSPgEgI. At 5–6 days after super-
infection, Met-gE protein was present at sites in the
cytoplasm distant from the TGN and at plasma mem-
branes (Fig. 5B, arrows). However, even at these later
time points, Met-gE protein was localized in a punctate
pattern in the absence of gI (Fig. 5B, 140 h). Dox-induced
uninfected cells continued to show perinuclear Met-gE
protein at the 140-h late time point (Fig. 5B, top). The data
suggest that gI facilitates the normal cytoplasmic distri-
bution of gE within infected cells, although expression of
FIG. 3. Localization of gE in Met-gE melanoma cells. VZV gE-expressing cells were grown on glass coverslips and incubated in the absence or
presence of 1.0 g/ml Dox for 3 days. Met-gE cells were fixed and permeablized. The cells were incubated with mouse anti--adaptin monoclonal
antibody (AP-1) and human anti-VZV polyclonal antibody (GK). Cells were subsequently washed with PBS–BSA before incubation with goat anti-mouse
IgG, conjugated with Texas Red and goat anti-human IgG, and conjugated with FITC. Cells were examined by confocal microscope. AP-1 expression;
gE staining; and the overlay of AP-1 and gE staining are shown. Bar, 10 m.
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VZV proteins other than gI is associated with some
intracellular transport of gE to sites beyond the TGN.
Analysis of the effect of VZV superinfection of Met-gE
cells on the synthesis of Met-gE protein
The formation of mature gE protein in cells infected
with VZV has been studied extensively (reviewed by
Grose, 1990). Under conditions described by Montalvo et
al. (1985), the gE precursor polypeptide is 75K, the high-
mannose intermediate form is 81K, the intermediate O-
linked glycoprotein is 83K, and the final mature O-linked
and N-linked glycoprotein is 94K. In the current experi-
ments, Met-gE cells were inoculated with vOka-MSPgE
or vOka-MSPgEgI and harvested at different time inter-
vals. Mock-infected Met-gE cells grown in the presence
of Dox were used as a control. In these cells, an 80K form
of gE was detected at Day 1, and three forms of 80K, 90K,
and 96K MWwere detected at Days 2 and 3 (Figs. 6A and
6B, lanes 1–3). When Met-gE cells were infected with
vOka-MSPgE in the presence of Dox, three bands of 80K,
90K, and 96K were detected at Day 1. This result resem-
bled observations with uninfected Met-gE cells after Dox
induction. The lower 80K band is probably the high-
mannose form of gE which is endo-H sensitive. There
was no change in the 80K form of Met-gE at Days 2 and
3 in induced Met-gE cells (Fig. 6, lanes 2 and 3). How-
ever, this protein band was diminished by Days 2 and 3
after infection of Met-gE cells with vOka-MSPgE (Fig. 6A,
lanes 8 and 9). By Day 3, most Met-gE was processed to
the final 94K form (Fig. 6A, lane 9). These data suggest
that viral proteins, including gE itself, may accelerate the
maturation of gE during the complex stages of gE pro-
cessing. When Met-gE cells were infected with vOka-
MSPgE in the absence of Dox, some gE was detected
(Fig. 6A, lanes 4–6). These observations suggest that VZV
transactivator(s) may bind the Tet-responsive PhCMV-1
promoter in the Met-gE cells and turn on low-level gE
expression without Dox induction.
Infection with vOka-MSPgEgI was used to determine
whether gI contributed to gE maturation. When Met-gE
cells were infected with vOka-MSPgEgI in the pres-
ence of Dox, the 80K band was detected at Day 1 (Fig.
6B, lane 7). This band is the same size as the endo-H-
sensitive form of gE (Fig. 6B, lane 1). As was observed
FIG. 4. Construction of VZV pvSpe21 cosmids with deletion of VZV ORF68 or ORF67-68 and insertion of MSP ORF68. gE deletion mutants were
constructed with VZV DNA cosmids derived from the Oka strain. Line 1, schematic diagram of the VZV genome with the location of gE; line 2,
overlapping segments of the VZV genome used to construct the VZV cosmids; line 3, the subcloned SacI fragment from pvSpe21 containing gE; line
4, deletion of gE; line 5, insertion of MSPgE (ORF68) as well as 454 bp of noncoding sequence (271 bp upstream and 183 bp downstream) into a unique
AvrII site of pvSpe21gE to generate MSPgE@AvrIIgE; line 6, insertion of MSPgE ORF as well as 454 bp of noncoding sequence into a unique AvrII
site of pvSpe21gI to generate MSPgE@AvrIIgE/gI.
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FIG. 5. gE requires VZV infection to reach the cell surface in melanoma cells. Met-gE cells were either mock infected or infected with vOka-MSPgE
or vOka-MSPgEgI and selected with G418. A. After 48-h incubation in the presence of Dox, vOka-MSPgE- or vOka-MSPgEgI-infected cells were
fixed and permeablized. B. After 70, 114, and 140 h of incubation in the presence of Dox, vOka-MSPgEgI-infected cells and uninfected (UI) cells were
fixed and permeablized. The cells were incubated with mouse anti-gE monoclonal antibody (3B3) and rabbit anti-VZV IE62 polyclonal antibody. Cells
were subsequently washed with PBS–BSA before incubation with goat anti-mouse IgG, conjugated with FITC and goat anti-rabbit IgG, and conjugated
with Texas Red. Bar, 10 m.
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when Met-gE cells were infected with vOka-MSPgE, this
band was decreased at Days 2 and 3. Two gE forms, of
approximately 90K and 96K, could be seen at Days 2 and
3 (Fig. 6B, lanes 8 and 9). However, in contrast to vOka-
MSPgE superinfection, the mature, smaller 94K gE did
not emerge as the predominant form (Fig. 6A, lanes 8
and 9). This result is consistent with observation of Yao
et al. (1993), who found that the molecular weight of gE
from infected cells resembled that from gE/gI cotrans-
fected cells, while gE from singly transfected cells was
not processed to the 94K form. Met-gE was not ex-
pressed when Met-gE cells were infected with vOka-
MSPgEgI in the absence of Dox (Fig. 6B, lanes 4–6).
This difference from noninduced MetgE cells infected
with vOka-MSPgE probably reflects the fact that gI dele-
tion mutants replicate much less efficiently than intact
VZV (Mallory et al., 1997). The failure of gE to shift to the
predominant 94K mature form in the absence of gI is
consistent with our previous analyses of vOkagI and
the gI partial deletion mutant, vOkagI-N (Mallory et al.,
1997).
DISCUSSION
VZV, like other alphaherpesviruses, has genes that
encode gE and gI proteins within the short unique region
of the genome, and gE and gI form heterodimers in
infected cells (Litwin et al., 1990). The gE/gI heterodimer
complex mediates cell–cell spread and has been shown
to be important for infection of neuronal and epithelial
cells by HSV and PRV (Card and Enquist, 1995; Dingwell
et al., 1994, 1995; Dingwell and Johnson, 1998; Tirabassi
and Enquist, 2000). VZV differs from the other alphaher-
pesviruses, in that gE and gI are the only two glycopro-
teins encoded in the VZV Us region. VZV gE is a multi-
functional protein that has been considered likely to be
required for production of infectious virions. This concept
is supported by the evidence for its role in VZV envelop-
ment in the TGN, where gE has been shown to interact
with other viral glycoproteins and tegument proteins
(Gershon et al., 1994). VZV gE also enhances cell–cell
contact in polarized epithelial cells, suggesting a role in
facilitating cell–cell spread (Mo et al., 2000).
The deletion of the gE homologues of other alphaher-
pesviruses has adverse effects on replication but does
not result in a complete inhibition of virion synthesis
(Balan et al., 1994; Jacobs, 1994). In contrast, we specu-
lated that gE might be essential for VZV replication be-
cause of the known functions of gE and because we
recovered no infectious virus from melanoma cells trans-
fected with cosmids when both ORF68 (gE) and ORF67
(gI) had been deleted (Mallory et al., 1997). VZV gI was
identified as nonessential in melanoma cells although its
deletion blocked viral replication in Vero cells (Cohen
and Nguyen, 1997; Mallory et al., 1997).
The current experiments document that gE is required
for VZV replication. No infectious virus was made when
melanoma cells were transfected with cosmids from
which ORF68 alone was removed, and infectivity was
restored when the ORF68 sequence was inserted into a
nonnative AvrII site in the Us region of the VZV genome.
These repair experiments indicate that failure to gener-
ate infectious virus when ORF68 was deleted is not likely
to have resulted from random mutations elsewhere in the
VZV genome. This conclusion is supported further by the
reproducibility of the results obtained when ORF68 de-
letion and repair experiments were repeated with sepa-
rately derived cosmids. In addition, these experiments
showed that infectivity for melanoma cells was restored
if gE was reinserted into recombinants that still had
deletions of gI. The growth characteristics and plaque
morphologies of recombinants obtained after replacing
ORF68 were typical of intact VZV, and of gI deletion
mutants, respectively. These observations about gE par-
FIG. 6. VZV gE modification after infection of Met-gE cells with
vOka-MSPgE or vOka-MSPgEgI. Met-gE cells were infected with
vOka-MSPgE or vOka-MSPgEgI. After 1 week of growth in the pres-
ence of G418, the infected cells were transferred to 6-well plates for 1,
2, and 3 days with () or without () Dox. Cells were harvested and the
cell lysates were separated by 10% SDS–PAGE and transferred to a
nitrocellulose membrane. Mouse anti-gE monoclonal antibody (3B3)
was used as the probe and detected with anti-mouse antibody conju-
gated with HRP.
182 MO ET AL.
allel our results with gK, encoded by ORF5, which was
also proved to be essential for VZV replication by dele-
tion and repair at a nonnative site in the VZV genome (Mo
et al., 1999).
Attempts to derive melanoma cells that express gE
have not yielded stable cell lines, suggesting that con-
stitutive gE production was incompatible with survival of
melanoma cells (unpublished observations; Litwin et al.,
1992). However, we found that doxycyline-regulated ex-
pression permitted the construction of gE-expressing
cell lines (Met-gE cells). After induction, Met-gE cells
exhibited relatively limited distribution of gE, with most
protein detected in perinuclear areas, where it colocal-
ized with -adaptin, a TGN marker. Since VZV gE ap-
pears to undergo a continuous cycling between the TGN
and plasma membranes, these steady-state experiments
are consistent either with gE retention in the TGN or with
the failure of gE to remain associated with the plasma
membrane long enough to permit detection at this site. In
all experiments with induced Met-gE cells, gE was never
detected on plasma membranes.
In order to assess the effect of VZV replication on the
distribution of Met-gE and its maturation, VZV recombi-
nants were made that expressed the gE from VZV MSP.
MSP gE contains a D150N substitution that blocks bind-
ing of the monoclonal antibody, 3B3 (Santos et al., 1998).
The recombinant virus, vOka-MSPgE, was further modi-
fied to delete gI. These recombinant viruses, vOka-
MSPgE and vOka-MSPgEgI, had growth characteristics
in melanoma cells that were indistinguishable from rOka
and rOkagI (Mallory et al., 1997). When Met-gE cells
were infected with vOka-MSPgE, Met-gE protein exhib-
ited the pattern of intracellular gE localization found in
VZV-infected melanoma cells. The cytoplasmic and
plasma membrane distribution suggested that Met-gE
protein retained the same functional capacity to associ-
ate with membranes of intracellular vesicles or or-
ganelles as authentic gE that is made during viral repli-
cation, but that viral cofactors were needed to permit the
characteristic localization of gE within melanoma cells.
Based upon our prior observations about VZV gE dim-
mers (Olson et al., 1997), the simplest explanation is that
MSP gE forms a dimmer with Met-gE within the ER and
that this dimmer can then be transported through the
Golgi to the plasma membrane.
Although gI can be deleted from VZV, our full and
partial gI deletion mutants, vOkagI, vOkagI-C, and
vOkagI-N, exhibited decreased syncytium formation,
punctate gE distribution on cell surfaces, and reduced
infectious virus yields in melanoma cells (Mallory et al.,
1997). When these mutants were evaluated in human
fibroblasts, the TGN cisternae became adherent, viral
envelopment was impaired, and virions did not reach
post-Golgi structures (Wang et al., 2001). In the current
experiments, the distribution of cellular Met-gE was
changed in vOka-MSPgEgI-infected Met-gE cells.
Met-gE protein was detected more diffusely in the cyto-
plasm of superinfected cells even in the absence of gI.
However, the kinetics of gE redistribution was delayed
by 3–4 days compared to that of Met-gE cells that were
infected with vOka-MSPgE. The punctate pattern of
Met-gE localization resembled the aberrant gE localiza-
tion observed when melanoma cells were infected with
full or partial gI deletion mutants (Mallory et al., 1997).
Based upon experiments in HeLa cells, gE may not be
retrieved efficiently from the plasma membrane in the
absence of gI and gI was the dominant protein in mod-
ulating the plasma membrane trafficking of the gE:gI Fc
receptor complex (Olson and Grose, 1998). In our exper-
iments, some Met-gE appeared beyond perinuclear sites
in the cytoplasm of infected cells even in the absence of
gI, indicating that other viral proteins can compensate in
part for the lack of gI accessory functions. Since recent
studies demonstrate that gB interacts with gE to form
syncytia, we speculate that gB could contribute to gE
trafficking in the absence of gI (Maresova et al., 2001).
Alternatively, the effect may be due to gE:gE dimerization
alone (Olson et al., 1997).
The typical processing of gE in VZV-infected cells
results in the predominance of a mature form of approx-
imately 94K within 72 h. Some differences in gE matura-
tion were observed between Met-gE cells and Met-gE
cells infected with vOka-MSPgE. Induced Met-gE protein
was detected as 75–80 K, 90K, and 96K forms, whereas
Met-gE protein underwent the expected shift to the sin-
gle 94K mature form when Met-gE cells were infected
with vOka-MSPgE. In contrast to superinfection with in-
tact VZV, the emergence of the predominant 94K form
was inhibited when Met-gE cells were infected with
vOka-MSPgEgI. Our previous analysis of melanoma
cells infected with vOkagI, vOkagI-C, which ex-
presses the first 209 amino acids of gI, or vOkagI-N,
showed that the gI N-terminus was required to achieve
the shift to the relative predominance of the mature 94K
gE. The current observations provide further evidence
that gI facilitates posttranslational modification of gE
(reviewed by Grose, 1990; Wang et al., 2001). The N-
terminus of gI is known to contain a gE/gI binding do-
main (Kimura et al., 1998). Further, within a transient
transfection system, gE endocytosis is enhanced sub-
stantially when gI is cotranslated (Olson and Grose,
1998). Nevertheless, intact gI, including its C-terminal
domain, was required to produce the usual titers of
infectious VZV, normal plaque morphology (Mallory et al.,
1997), and segregation of viral and cellular proteins dur-
ing virion envelopment in the TGN (Wang et al., 2001).
When Met-gE cells were evaluated for their capacity to
complement the deletion of gE, no infectious virus was
recovered after transfection of the cosmid, pvSpe21gE,
along with the other three intact vOka cosmids, in re-
peated experiments. The failure to generate infectious
virus may be explained by the relatively limited gE syn-
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thesis, especially of the mature 94K form, and the kinet-
ics of gE synthesis may not be sufficient to achieve
complementation. When induced Met-gE cells were su-
perinfected, they remained fully permissive for VZV rep-
lication. Although we had hoped to use the Met-gE cells
to determine whether the cell surface expression of gE
could interfere with VZV infection in the way that gD
expression prevents HSV entry (Campadelli-Fiume et al.,
1988; Johnson and Spear, 1989), the limited expression of
Met-gE on plasma membranes did not permit us to
address this question.
In summary, these observations confirm the hypothe-
sis that gE is essential for VZV replication, based upon
the definitive criterion of restored infectivity after reinser-
tion of ORF68 into the genome. The results using vOka-
MSPgE superinfection show that the mutant MSP gE has
the capacity to rapidly alter the maturation and distribu-
tion of VZV gE. Finally, the experiments provide further
evidence that VZV gI, while not required for infectivity,
affects the kinetics of gE maturation and facilitates its
intracellular distribution for assembly of infectious virus
particles.
MATERIALS AND METHODS
Construction of plasmids and cosmids
The complete genome of the VZV vaccine Oka strain
(vOka) is contained in four overlapping SuperCos 1 cos-
mids vectors: pvFsp4 (1–33,211), pvSpe5 (21,875–62,008),
pvPme19 (53,877–96,188), pvSpe21 (94,208–124,884) (Fig.
4, line 2). ORF68 extends from nucleotides 115,808 to
117,676, located within the unique short region in the
cosmid pvSpe21 (Fig. 4, line 3). A 6-kb DNA fragment
from nucleotides 111,911 to 117,989 that contained ORF68
was subcloned into the plasmid vector pBS to generate
pSac6A (Mallory et al., 1997). VZV ORF68 was amplified
from pSac6A using primers SacIIgEf and BamHIgEb (5-
GCATCCGCGGATGGGGACAGTTAAT-3 and 5-GCATG-
GATCCCGGTGATCACCGGGT C-3). The PCR product
was ligated into the pCR3.1 TA cloning vector, yielding
the plasmid, pCR-VZVgE. pCR-VZVgE and pTRE vector
(Clontech Laboratories, Inc., Palo Alto, CA) were di-
gested with SacII/BamHI, and the 1.8-kb fragment from
pCR-VZVgE was isolated and ligated into pTRE SacII/
BamHI to generate pTRE-gE. The expression of gE was
driven by the Tet-responsive PhCMV-1 promoter.
The plasmid, pLITMUS ORF66-68, was constructed by
inserting the 6.6-kb AatII/AvrII fragment from Spe21 into
pLITMUS28 vector. For full deletion of VZV gE, primers
gEN (5-TGAATTACAGGCGACCCTCGG-3) and gEC
(5-TGATCACCGAACCGGGGCAAC-3) were designed to
amplify the sequence adjacent to the gE coding region
by using pLITMUS ORF66-68 as the template. The
PCR product was gel-purified and ligated to generate
pLITMUS ORF66-68gE. After AatII/AvrII digestion and
gel purification, a 3.8-kb DNA fragment from pLITMUS
ORF66-68gE and a 12.5-kb DNA fragment from
pLITMUS28/VZV were ligated to yield pLITMUS28/
VZVgE. Spe21TRs and pLITMUS28/VZVgE were di-
gested with AvrII/SrfI, respectively, and the 16.5-kb
fragment from Spe21TRs and 8.9-kb fragment from
pLITMUS28/VZVgE were ligated to generate Spe21TRs/
gE. Spe21TRs/gE was digested with AvrII/NheI; the
13.5-kb fragment was isolated and ligated into the
21.2-kb fragment of Spe21AvrII generated by the AvrII/
NheI cleavage to produce Spe21gE (Fig. 4, line 4).
Two cosmids, Spe21gE-MSPgE@Avr and Spe21gE/
gI-MSPgE@Avr, were made to restore the deletion of
the gE coding region from Spe21gE or Spe21gE/gI
(Fig. 4, lines 5 and 6). Plasmid pRS2 was digested with
AvrII and the DNA fragment containing the MSP ORF68
as well as 454 bp of noncoding sequence (271 bp up-
stream and 183 bp downstream) was isolated. The 2.3-kb
fragment was ligated into AvrII linearized cosmids,
Spe21gE or Spe21gE/gI, to produce cosmids
Spe21gE-MSPgE@Avr and Spe21gE/gI-MSPgE@Avr,
respectively.
Cells and gE-expressing melanoma cell lines (Met-gE)
Human melanoma cells were grown in Dulbecco’s
minimal essential medium supplemented with 10% fetal
calf serum, penicillin–streptomycin, and fungizone. The
regulator plasmid, pTet-On (Clontech), was transfected
into melanoma cells using the Lipofectin method (Gibco
BRL, Grand Island, NY). After 4 weeks of selection in
medium containing 300 g/ml of G418, the surviving
clones were isolated and expanded for further screen-
ing. These stably transfected cells were designated the
Tet-On melanoma cells (Met cells).
Met melanoma cell lines were screened using a tran-
sient luciferase expression assay. One day before the
transient transfections, 1–2 105 Met cells were seeded
in 2 ml medium into each well of a 6-well plate. The
transient transfections with pTRE-Luc were carried out
using Lipofectin. Doxycycline (1 g/ml) was added to
three of the wells. The cells were incubated for 48 h and
harvested for the luciferase expression assay (3 Dox, 3
Dox). The reaction was placed in a luminometer, and
the light produced was measured for a period of 10 s.
Over 100 stably transfected clones were analyzed by
transient transfection with pTRE-Luc. The clones desig-
nated Met19 and Met25 showed relatively low back-
ground and high Dox-dependent induction.
The second stable transfection involved the cotrans-
fection of pTRE-gE and pTK-Hyg (Clontech) into the can-
didate Tet-On cell line (Met19). The pTK-Hyg plasmid
allowed for selection with hygromycin B. After 4 weeks of
selection in medium containing 300 g/ml of hygromycin
B, the surviving clones were isolated and expanded for
further study. These stably transfected cells were desig-
nated Met-gE cell lines. Expression of gE was assessed
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by Western blot and immunofluorescence. Two clones
with a low background of gE in the absence of Dox and
high induction of gE in the presence of Dox were used at
low passage (10) for all experiments.
Plasmid DNA with the insert was sequenced using
ORF68 sequence primers, gE1837 (5-CACCGGATA-
AAAGCGTACTG-3), gE2311 (5-GCTTCAACATGCCCGT-
TAAA-3), gE2784 (5-GGGCGTAGGGTTTCTTGTTT-3),
and gE3257 (5-CAATGAGTCTTTGGCCTTGG-3). No nu-
cleotide changes were found (data not shown).
Western blot analysis
These samples were incubated at 37°C for 2 h before
SDS–PAGE analysis. Aliquots of cell lysates from mela-
noma cells infected with VZV recombinants were mixed
with SDS sample buffer and boiled at 95°C for 5 min.
Proteins were separated by 8.5 or 10% SDS–PAGE and
transferred to a nitrocellulose membrane. Mouse anti-gE
monoclonal antibody, designated 3B3, at a dilution of
1:5000 to 1:10,000 was used as the probe and detected
with donkey anti-mouse antibody conjugated with HRP
(Amersham, Inc., Buckinghamshire, UK) at a dilution of
1:3000 to 1:5000.
Transfection, DNA isolation, and confirmation of
mutants
Cosmid transfection and viral DNA isolation proce-
dures have been described previously (Mo et al., 1999).
PCR was used to confirm the expected changes in frag-
ment sizes in cosmids and DNA from recombinant vi-
ruses and to sequence the regions spanning the ORF68
deletions and MSPgE insertion into the AvrII site. The
vOka gE region was amplified by PCR using primers
gE1837 and gIf (Mo et al., 2000) to verify the deletion of
gE from the native site. The AvrII region was amplified by
PCR to verify the insertion of the MSPgE cassette at the
AvrII site 112853. The primers used to determine the
sizes of insertion were VZV112580 and VZV113686 (Mal-
lory et al., 1997). The sequence of the inserted ORF68
was verified as identical to VZV MSP ORF68 by the
Stanford shared sequencing facility. The recombinant,
vOka-MSPgE, that expresses the gE from VZV MSP
strain, was generated from vOka cosmids by cotransfec-
tion. The second recombinant was vOka-MSPgE without
ORF67 (gI), designated vOka-MSPgEgI.
Genomic DNA PCR analysis
gE deletion cosmids were cotransfected into gE-ex-
pressing cells (Met-gE) in the medium containing 1
g/ml Dox. Cells were split every 3–4 days at a 1:3 ratio
over 9 to 12 days. Cellular and/or viral DNAs were ex-
tracted from the transfected cells using DNAzol (Gibco
BRL). In cells transfected with intact Spe21 and other
three cosmids, the ORF68 sequence would be detected
by PCR. In contrast, if Spe21gE recombined with the
other cosmids to yield viral genome, PCR would show no
ORF68 detected. When primers gEf (Mo et al., 2000) and
gE1837 which start at the gE N-terminal and end at 71 bp
after gE C-tail are used to amplify diluted DNA template,
intact ORF68 in Met gE cells cannot be detected be-
cause its DNA annealing site for the second primer is
absent.
Immunofluorescence analysis of the distribution of gE
Met-gE cells were infected with vOka-MSPgE or vOka-
MSPgEgI and harvested when approximately 75% of
cells exhibited cytopathic changes. Met-gE cells (3 106
cells/T75 tissue culture flask) were incubated for 2 h
before the addition of infected cells (3  105 cells) to the
flask. The infected or mock-infected Met-gE cells were
selected in medium containing G418, 300 g/ml, for 1
week. The infected or mock-infected Met-gE cells were
then grown on glass coverslips in medium with Dox, 1
g/ml, or no drug. After incubation for 24–72 h, cells
were fixed and permeablized and incubated with anti-gE
mAb, 3B3, and rabbit anti-VZV IE62 polyclonal antibody.
The cells were washed with PBS–BSA before incubation
with goat anti-mouse IgG, conjugated with FITC and goat
anti-rabbit IgG, conjugated with Texas Red. Cells were
examined with a Nikon fluorescence microscope using a
40X objective or a Molecular Dynamics MultiProbe 2010
laser scanning confocal microscope. Fluorescence im-
ages of stained cells were recorded using Kodak Ekta-
chrome Elite II (ASA 400) films. Developed positive im-
ages were then digitized with a slide scanner.
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